Most engineered human cells created for studying disease, Health News, ET HealthWorld

Headline: Revolutionary Genome Editing: Unveiling Our DNA’s Unexpected Flexibility

In a groundbreaking feat, scientists from leading institutes have engineered the most complex human cell lines to date, challenging our understanding of genetic tolerance. The teams, hailing from the Wellcome Sanger Institute, Imperial College London, Harvard University, and the University of Washington, have uncovered our genomes’ surprising ability to withstand significant structural alterations.

Using a novel approach combining CRISPR prime editing and the strategic integration of recombinase sites, researchers have successfully ‘shuffled’ the genomes of human cell lines on an unprecedented scale. This resulted in thousands of structural variants, including large deletions, within single experiments—a first for mammalian genomes.

The study, published recently, reveals that human genomes can tolerate substantial structural changes, such as large deletions, as long as essential genes remain intact. Astonishingly, even deletions in non-coding regions seemed to have little impact on gene expression in the rest of the cell.

Dr. Jonas Koeppell, co-first author now at the University of Washington, likens these variants to "ripping out a whole page" of a book. Until now, studying such variants has been challenging, but this innovative approach has opened new avenues for exploration.

The findings suggest that much of our non-coding DNA may be dispensable, potentially narrowing the search for disease-linked structural variations. Moreover, these tools could enable the creation of streamlined cell lines with evolved properties, aiding drug research and bioengineering.

Raphael Ferreira, another co-first author from Harvard Medical School, attributes the success to combining cutting-edge genome engineering with open, collaborative science across global borders. Professor Tom Ellis, an author of the study from Imperial College London, believes this work signals a new era in studying genome structure, once thought to take decades and vast resources.

In essence, these studies demonstrate a "step change" in creating and evaluating structural variation in human genomes, paving the way for more accurate disease association studies and bioengineering opportunities.

So, what does this mean for us? While our understanding of genome structure is still evolving, one thing is clear: our DNA is more adaptable than we thought, and scientists are just getting started in unraveling its secrets.